Pyrrolidin-3-ylmethanol hydrochloride is primarily used in the pharmaceutical industry as a key intermediate in the synthesis of various bioactive compounds. It plays a significant role in the development of drugs targeting the central nervous system, particularly for neurological disorders such as Parkinson's disease and schizophrenia. Its structural properties make it suitable for modifying and enhancing the pharmacokinetic profiles of therapeutic agents. Additionally, it is utilized in research settings for the preparation of ligands and receptor modulators, aiding in the study of biochemical pathways and drug discovery.